×
Conecte-se
Vamos começar
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Descobrir todas as categorias
Report -
· Os inhibidores de interleucinas específicas (brodalumab, ixekizumab, secukinumab e ustekinumab) poderán valorarse tamén como primeira liña de tratamento biolóxico en aqueles
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form